Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Drug Targets 10, 6881
Antimicrobial peptides and innate lung defenses: role in infectious and noninfectious lung diseases and therapeutic applications
Dzieyc, K., Litwin, T
As a pillar of the Army FUZE portfolio, SBIR|STTR opportunities help small businesses break through the typical barriers of working in government research and development by opening doors to sustained funding and clear transition pathways
BPC-157 is not FDA-approved for human use , and we currently lack large, high-quality human clinical trials proving its effectiveness
In studies using tendon fibroblasts in culture (Chang et al., 2011), the introduction of BPC-157 was observed to induce a dose-dependent increase in the phosphorylation of FAK and paxillin, another key focal adhesion protein
US$ 29.93
US$ 28.39
US$ 22.20
US$ 20.51
US$ 21.03
US$ 25.11
US$ 21.80
US$ 29.71
US$ 29.50